Investing

Nine Analyst Stock Picks Trading Under $10 With Huge Implied Upside

Stocks remain close to all-time highs, but investors are getting used to being told that the bull market has become a stock picker’s market. 24/7 Wall St. reviews dozens of analyst research reports each weekday, looking for new ideas and hidden gems for our readers. We generally see many upside and downside stocks in these reports, but sometimes the stocks trading under $10 have incredible upside price targets from analysts.

24/7 Wall St. would caution readers to not ignore the fact that stocks trading under $10 are often among the riskiest stocks in the market. To prove a point, only four of the members in the S&P 500 Index have share prices under $10 — and only one of them trades under $9! Still, many investors are attracted to lower-priced stocks as they feel like there is larger room for upside.

Unlike the Dow Jones Industrial Average stocks, many analyst calls in these lower-priced and small-cap stocks often come with upside projections of 50% upside, or 100% — or even exponential upside. You just do not see that sort of call too often in DJIA components.

Another consideration on risk in most of the stocks under $10 is that almost all of these selected from this past week would fail the “widows and orphans” suitability test. This is what brokers and financial advisors have to consider when it comes to ethics and suitability for clients.

So, now you have your caveat emptor warnings and you can see the major calls in stocks under $10 from this past week. To generate these nine stocks under $10, we reviewed more than a couple hundred analyst report summaries.

These are the nine analyst stocks we tracked this past week that were trading under $10 and have huge implied upside, if the analysts are correct in their calls.

Ampio Pharmaceuticals Inc. (NYSEMKT: AMPE) saw a gain of more than 4% on Friday to $8.31, after Jefferies started coverage with a Buy rating and assigned a $14 price target. The driver is enrollment in its eye study trial has ended. While this biotech player has an implied upside of 68% to the Jefferies target price, the 52-week range is $5.06 to $10.86, and a call from Citigroup in May gave Ampio a whopping $21 price target.

Atlantic Power Corp. (NYSE: AT) is back again in the analyst calls under $10, with Imperial Capital starting coverage as Buy and with a $7 price target this last Thursday. The $473 million small cap power generation player has a 52-week range of $2.11 to $5.36. This $7 target is the highest among analysts by far, and shares rose 4% on the upgrade and another gain of almost 6% on Friday to close out at $3.92. Imperial’s upside was nearly 100% when it made the call, and the new street-high target is still close to 80%.

Coeur Mining Inc. (NYSE: CDE) saw keen analyst action this week, with one analyst daring to call this $8.97 stock a double. Sterne Agee reiterated is Buy rating and assigned an $18 target price (more detailed coverage of the call). The consensus price target is closer to $11.00. Another call was seen from BMO Capital Markets, raising its rating to Market Perform from Underperform (sell), and its price target was raised to $9.50 from $7.00.

Dot Hill Systems Corp. (NASDAQ: HILL) is perhaps an overlooked and forgotten software and hardware player in storage. Shares closed at $4.41 on Friday after falling almost 4%, but Roth Capital Partners started coverage on Friday with a Buy rating and gave it a price target of $7.00. This implies nearly 60% upside, and the consensus price target is $6.00 on the stock.

ALSO READ: Ten Stocks That Will Drive the DJIA to 20,000

DragonWave Inc. (NASDAQ: DRWI) saw a very unusual gain of almost 14% on Friday. The driving force was an analyst report from CIBC World Markets with a $3 price target. That would imply upside of more than 50%, even from the $1.93 post-upgrade gain on Friday. Just keep in mind that this was a $1.50 stock at the close of trading on Wednesday, so it has already ramped up 29% in just the past two trading sessions and on strong trading volume.

Office Depot Inc. (NYSE: ODP) was covered much more favorably than rival Staples by Morgan Stanley, with an Equal Weight rating versus an Underweight rating. The Equal Weight might not be excessively bullish, but the $6.35 price target implied upside of 12% from the $5.66 prior close and slightly more than the $5.62 closing price on Friday. This makes multiple times that Office Depot has been featured positively by analysts in recent weeks.

Sirius XM Holdings Inc. (NASDAQ: SIRI) was reiterated as Buy at Merrill Lynch earlier in the week in more detailed coverage. While the consensus price target is $4.25, the Merrill Lynch team maintained its $5.00 price target. Sirius XM closed at $3.43 on Friday, implying upside potential of 45%. What should really stand out here is that this is the street-high price target of all Wall Street analysts.

Turtle Beach Corp. (NASDAQ: HEAR) was started with an Outperform rating on Thursday by Northland Securities. The $340 million audio technology player was at $9.43 prior to the call, but by Friday’s close the stock was down to $9.01. Northland’s $15 price target now implies 66% potential upside. Its 52-week range is $7.58 to $17.90, and at least one other analyst sees the stock valued even above $20.

USA Technologies Inc. (NASDAQ: USAT) was picked up in new coverage by H.C. Wainwright & Co. on Friday with a Buy rating and a $2.65 price target. This microcap wireless and payment player closed at $2.02 on Friday, implying more than 30% upside remains. Its 52-week range is $1.40 to $2.48, and its market cap of $72 million values it at well under two-times current revenue trends.

ALSO READ: Seven Alternative Energy Stocks With Significant Upside Potential

Last week’s high upside analyst picks under $10 included shares of Apollo Investment, Atlantic Power, BlackBerry, Ballard Power, Compugen, Orbitz, MeetMe and more for a total of 11 stocks. Also, our coverage of Friday’s key analyst upgrades and downgrades included Alcoa, Cigna, Intel, Molina Healthcare, Teva Pharmaceutical, UnitedHealth and more than a dozen additional stocks.

Is Your Money Earning the Best Possible Rate? (Sponsor)

Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.

However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.

There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.